M P Sullivan|S Lockhart|H Boren - JoVE Visualize

Showing results (141-150 of 181) with videos related to

Pageof 19

Sort By:

Medical and Pediatric Oncology|January 1, 1984

Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group studyE Hvizdala, D H Berry, T Chen, et al.

Head & Neck Surgery|January 1, 1986

Primary lymphoma of the mandibleK T Robbins, L M Fuller, J Manning, et al.

Blood|July 15, 1991

DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damageF B Taylor, A C Chang, G T Peer, et al.

The Journal of Applied Laboratory Medicine|October 23, 2019

Rapid Rule Out of Culture-Negative Bloodstream Infections by Use of a Novel Approach to Universal Detection of Bacteria and FungiAndrew J Rogers, Daniel S Lockhart, Rebecca Clarke, et al.

BMC Geriatrics|May 20, 2016

A meta-review of stress, coping and interventions in dementia and dementia caregivingK J Gilhooly, M L M Gilhooly, M P Sullivan, et al.

The Journal of Urology|February 25, 2000

Characterization of ureteral dysfunction in an experimental model of congenital bladder outlet obstructionW F Santis, M P Sullivan, R Gobet, et al.

Cancer|March 1, 1975

Influence of staging celiotomy in localized presentations of Hodgkin's diseaseJ F Gamble, L M Fuller, R G Martin, et al.

The American Journal of Pediatric Hematology/Oncology|January 1, 1991

High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group studyM P Sullivan, M Brecher, I Ramirez, et al.

Cancer|January 15, 1985

Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded)M P Sullivan, J Boyett, J Pullen, et al.

Cancer|May 1, 1977

New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patientsL M Fuller, H Madoc-Jones, J F Gamble, et al.

Pageof 19

Showing results (141-150 of 181) with videos related to

Sort By:

Pageof 19

Medical and Pediatric Oncology|January 1, 1984

Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group studyE Hvizdala, D H Berry, T Chen, et al.

Head & Neck Surgery|January 1, 1986

Primary lymphoma of the mandibleK T Robbins, L M Fuller, J Manning, et al.

Blood|July 15, 1991

DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damageF B Taylor, A C Chang, G T Peer, et al.

The Journal of Applied Laboratory Medicine|October 23, 2019

Rapid Rule Out of Culture-Negative Bloodstream Infections by Use of a Novel Approach to Universal Detection of Bacteria and FungiAndrew J Rogers, Daniel S Lockhart, Rebecca Clarke, et al.

BMC Geriatrics|May 20, 2016

A meta-review of stress, coping and interventions in dementia and dementia caregivingK J Gilhooly, M L M Gilhooly, M P Sullivan, et al.

The Journal of Urology|February 25, 2000

Characterization of ureteral dysfunction in an experimental model of congenital bladder outlet obstructionW F Santis, M P Sullivan, R Gobet, et al.

Cancer|March 1, 1975

Influence of staging celiotomy in localized presentations of Hodgkin's diseaseJ F Gamble, L M Fuller, R G Martin, et al.

The American Journal of Pediatric Hematology/Oncology|January 1, 1991

High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group studyM P Sullivan, M Brecher, I Ramirez, et al.

Cancer|January 15, 1985

Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded)M P Sullivan, J Boyett, J Pullen, et al.

Cancer|May 1, 1977

New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patientsL M Fuller, H Madoc-Jones, J F Gamble, et al.

Pageof 19